Par Drugs And Chemicals Limited (NSE: PAR), ISIN INE04LG01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
PAR last traded at ₹95.51 (-0.34%), with a 52-week range of ₹78.05 to ₹122.43 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 73.41%, FIIs 0.00%, DIIs 0.09%, mutual funds 0.00%.
EquiSense Score (ECS): 31/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.